TIDM is an autoimmune disease that is characterized by slowly progressing pancreatic beta-cell destruction, resulting in a reduction of insulin secretion and, over the course of several years, the development of clinically evident insulin-dependent diabetes mellitus [1]. The gene discussed is INS; the disease is type 1 diabetes mellitus.